Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19

We retrospectively compared outcomes between patients who received compassionate care Remdesivir and whose who met criteria for Remdesivir, but did not received it due to period of unavailability. We observed comparable mortality rate and significantly higher mortality rate among patients with CrCl < 30 ml per minute.